The earnings call for Q1 2025 highlighted significant financial improvements, particularly in the German market, and successful cost-cutting measures that led to profitability. However, challenges in the Israeli market and specific deal cancellations were notable concerns.
Company Guidance
During the first quarter of 2025 earnings call, IM Cannabis reported significant improvements in their financial metrics, highlighting a net profit achievement. The company's gross margin improved by 87% compared to Q1 2024, while their German business saw an extraordinary revenue increase of 569%, effectively offsetting a 56% decline in Israeli revenue. IMC launched 12 new strains in Germany, contributing to EUR 3 million or 39% of cannabis FLOWR sales. The adjusted EBITDA swung from a loss of $2.2 million in Q1 2024 to a profit of $0.6 million, marking an improvement of approximately $3 million. The net profit for Q1 2025 was $0.2 million compared to a $6 million loss in the previous year. The company also reported a 4% increase in overall revenue to $12.5 million, driven by a $6.6 million revenue increase in Germany, despite a $6.1 million decline in Israel. Operating expenses decreased by 56%, reflecting enhanced efficiency, and the EBITDA improved by $5.6 million. IM Cannabis emphasized their strategic focus on the German market and cost-cutting measures, which resulted in a 94% increase in gross profit and a reduction in G&A expenses by 14%.
Net Profit Achievement
IM Cannabis reached net profit in Q1 2025, with significant improvements in financial metrics, including an 87% improvement in gross margin compared to Q1 2024.
German Market Growth
The German business grew by 569% versus Q1 2024, significantly offsetting the revenue decline in Israel. Germany's share of total revenue increased to 62%.
Cost Reduction Success
Total operating expenses decreased by 56% compared to Q1 2024, with significant reductions in G&A and selling and marketing expenses.
Positive EBITDA Turnaround
The adjusted EBITDA for Q1 2025 was a profit of $0.6 million compared to a loss of $2.2 million in Q1 2024, marking an improvement of nearly $3 million.
IM Cannabis Corp (IMCC) Earnings, Revenues Date & History
The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
IMCC Earnings-Related Price Changes
Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 15, 2025
$1.51
$1.62
+7.28%
Mar 31, 2025
$1.84
$1.51
-17.93%
Nov 14, 2024
$2.80
$2.83
+1.07%
Aug 14, 2024
$2.76
$2.99
+8.33%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does IM Cannabis Corp (IMCC) report earnings?
IM Cannabis Corp (IMCC) is schdueled to report earning on Aug 18, 2025, TBA Not Confirmed.
What is IM Cannabis Corp (IMCC) earnings time?
IM Cannabis Corp (IMCC) earnings time is at Aug 18, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.